ATORVASTATIN CALCIUM
- Product NDC
- 60760-883
- 11-digit product format
- 607600883
- Labeler code
- 60760
- Product ID
- 60760-883_2f76cd3b-fbfb-a193-e063-6294a90a1b32
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATORVASTATIN CALCIUM
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- ST. MARY'S MEDICAL PARK PHARMACY
- Application
- ANDA214344
- Marketing category
- ANDA
- Marketing start
- 2023-09-12
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 20 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 48A5M73Z4Q | ATORVASTATIN CALCIUM TRIHYDRATE | 344423-98-9 | ATORVASTATIN CALCIUM TRIHYDRATE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 60760-883-90 | 60760088390 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-883-90) | 2025-02-28 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| ATORVASTATIN CALCIUM | ST. MARY'S MEDICAL PARK PHARMACY | 2025-03-03 | HUMAN PRESCRIPTION DRUG LABEL | 1 |